Nardin, S.; Ruffilli, B.; Costantini, P.; Mollace, R.; Taglialatela, I.; Pagnesi, M.; Chiarito, M.; Soldato, D.; Cao, D.; Conte, B.;
et al. Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management. J. Cardiovasc. Dev. Dis. 2025, 12, 270.
https://doi.org/10.3390/jcdd12070270
AMA Style
Nardin S, Ruffilli B, Costantini P, Mollace R, Taglialatela I, Pagnesi M, Chiarito M, Soldato D, Cao D, Conte B,
et al. Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management. Journal of Cardiovascular Development and Disease. 2025; 12(7):270.
https://doi.org/10.3390/jcdd12070270
Chicago/Turabian Style
Nardin, Simone, Beatrice Ruffilli, Pietro Costantini, Rocco Mollace, Ida Taglialatela, Matteo Pagnesi, Mauro Chiarito, Davide Soldato, Davide Cao, Benedetta Conte,
and et al. 2025. "Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management" Journal of Cardiovascular Development and Disease 12, no. 7: 270.
https://doi.org/10.3390/jcdd12070270
APA Style
Nardin, S., Ruffilli, B., Costantini, P., Mollace, R., Taglialatela, I., Pagnesi, M., Chiarito, M., Soldato, D., Cao, D., Conte, B., Verdoia, M., Gennari, A., & Nardin, M.
(2025). Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management. Journal of Cardiovascular Development and Disease, 12(7), 270.
https://doi.org/10.3390/jcdd12070270
